Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 42Gastrointestinal 40Head & Neck 11Thoracic 10Gynecologic 9Other hematologic neoplasm 8Tumor-Agnostic 7Genitourinary 6Lymphoid 4Endocrine 3Sarcoma 2CNS 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1NET 1Dermatologic 1Classical hematology 1

Conditions

Thyroid Neoplasms 1Pneumothorax 1Pleural Neoplasms 1Parathyroid Neoplasms 1Mesothelioma 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Control Groups × Other solid neoplasm × Clear all
NCT01776385 2018-07-23

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma

Centre Hospitalier Universitaire de Nice

Phase NA Completed
9 enrolled
Head & NeckOther solid neoplasmThoracic

Mesothelioma, Parathyroid Neoplasms, Pleural Neoplasms, Pneumothorax, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡